Literature DB >> 29244647

Diagnosis and treatment of hyperkalemia.

Biff F Palmer1, Deborah J Clegg2.   

Abstract

Hyperkalemia results either from the shift of potassium out of cells or from abnormal renal potassium excretion. Cell shift leads to transient increases in the plasma potassium concentration, whereas decreased renal excretion of potassium leads to sustained hyperkalemia. Impairments in renal potassium excretion can be the result of reduced sodium delivery to the distal nephron, decreased mineralocorticoid level or activity, or abnormalities in the cortical collecting duct. In some instances, all 3 of these perturbations are present. Excessive intake of potassium can cause hyperkalemia but usually in the setting of impaired renal function. We discuss the clinical manifestations of hyperkalemia and outline an approach to its diagnosis and treatment.
Copyright © 2017 Cleveland Clinic.

Entities:  

Mesh:

Year:  2017        PMID: 29244647     DOI: 10.3949/ccjm.84a.17056

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  13 in total

1.  Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.

Authors:  Antoney Ferrey; Amy S You; Csaba P Kovesdy; Tracy Nakata; Mary Veliz; Danh V Nguyen; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Am J Nephrol       Date:  2018-06-07       Impact factor: 3.754

2.  Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism.

Authors:  Toru Ishikawa; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2021-12-27       Impact factor: 3.872

3.  Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: A retrospective observational cohort study using association rule mining.

Authors:  Dingwei Dai; Ajay Sharma; Paula J Alvarez; Steven D Woods
Journal:  J Multimorb Comorb       Date:  2022-05-12

4.  Intraoperative Hyperkalemia Due to Surgical Manipulation of a Thymoma.

Authors:  John W Mallett; Dustin L Hegland; Joseph C Goldstein
Journal:  Cureus       Date:  2021-03-08

5.  Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort.

Authors:  Ingrid Hougen; Silvia J Leon; Reid Whitlock; Claudio Rigatto; Paul Komenda; Clara Bohm; Navdeep Tangri
Journal:  Kidney Int Rep       Date:  2021-03-17

Review 6.  Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review.

Authors:  Claudia D'Alessandro; Alessia Benedetti; Antonello Di Paolo; Domenico Giannese; Adamasco Cupisti
Journal:  Nutrients       Date:  2022-01-04       Impact factor: 5.717

7.  Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.

Authors:  Aldo P Maggioni; Letizia Dondi; Felicita Andreotti; Silvia Calabria; Massimo Iacoviello; Marco Gorini; Lucio Gonzini; Carlo Piccinni; Giulia Ronconi; Nello Martini
Journal:  Eur J Clin Invest       Date:  2021-03-31       Impact factor: 4.686

Review 8.  Diagnostic Modalities in Critical Care: Point-of-Care Approach.

Authors:  Sasa Rajsic; Robert Breitkopf; Mirjam Bachler; Benedikt Treml
Journal:  Diagnostics (Basel)       Date:  2021-11-25

9.  Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis.

Authors:  Yaru Zhang; Ruiling Xu; Fanghao Wang; Youxia Liu; Junying Xu; Na Zhao; Fajuan Cheng; Lihong Long; Junya Jia; Shan Lin
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-18       Impact factor: 3.727

Review 10.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.